Terms: = Bone cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Prognosis
13 results:
1. Status and trends of RGS16 based on data visualization analysis: A review.
Wenbo L; Liangyu X; Zhiyong L; Gongchang Y; Yuanzhen C; Bin S
Medicine (Baltimore); 2024 Feb; 103(7):e36981. PubMed ID: 38363937
[TBL] [Abstract] [Full Text] [Related]
2. Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy
Miyamoto T; Sanford D; Tomuleasa C; Hsiao HH; Olivera LJE; Enjeti AK; Gimenez Conca A; Castillo TBD; Girshova L; Martelli MP; Guvenc B; Delgado A; Duan Y; Garbayo Guijarro B; Llamas C; Lee JH
Leuk Lymphoma; 2022 Apr; 63(4):928-938. PubMed ID: 35147482
[TBL] [Abstract] [Full Text] [Related]
3. [Sinonasal renal cell-like adenocarcinoma: a clinicopathological analysis of five cases].
Yuan CC; Zhai CW; Wang SY
Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1147-1151. PubMed ID: 33152820
[No Abstract] [Full Text] [Related]
4. Tumor-Treating Fields Inhibit the Metastatic Potential of Osteosarcoma Cells.
Oh JY; Lee YJ; Kim EH
Technol Cancer Res Treat; 2020; 19():1533033820947481. PubMed ID: 32938326
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological features of low-grade malignant endolymphatic sac tumors.
Wang HQ; Jie L; Shi HY
Pathol Res Pract; 2018 Mar; 214(3):431-435. PubMed ID: 29482989
[TBL] [Abstract] [Full Text] [Related]
6. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
Press DJ; Miller ME; Liederbach E; Yao K; Huo D
Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366
[TBL] [Abstract] [Full Text] [Related]
7. Unusual jaw metastasis from squamous cell lung cancer in heavy smoker: Two case reports and review of the literature.
Pezzuto A; Morrone M; Mici E
Medicine (Baltimore); 2017 May; 96(21):e6987. PubMed ID: 28538407
[TBL] [Abstract] [Full Text] [Related]
8. Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer.
Szendrői A; Szász AM; Kardos M; Tőkés AM; Idan R; Szűcs M; Kulka J; Nyirády P; Szendrői M; Szállási Z; Győrffy B; Tímár J
Oncotarget; 2016 Jul; 7(27):42086-42098. PubMed ID: 27244898
[TBL] [Abstract] [Full Text] [Related]
9. Cytologic Features and Immunocytochemical Profiles of Malignant Effusions with Metastatic Papillary Thyroid Carcinoma: A Case Series from a Single Institution.
Lew M; Pang JC; Roh MH; Jing X
Acta Cytol; 2015; 59(5):412-7. PubMed ID: 26587773
[TBL] [Abstract] [Full Text] [Related]
10. Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?
Deberne M; Ropert S; Billemont B; Daniel C; Chapron J; Goldwasser F
BMC Cancer; 2014 Jun; 14():416. PubMed ID: 24913188
[TBL] [Abstract] [Full Text] [Related]
11. Primary tumor prevalence has an impact on the constituent ratio of metastases to the jaw but not on metastatic sites.
Zhang FG; Hua CG; Shen ML; Tang XF
Int J Oral Sci; 2011 Jul; 3(3):141-52. PubMed ID: 21789963
[TBL] [Abstract] [Full Text] [Related]
12. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases.
Asioli S; Erickson LA; Sebo TJ; Zhang J; Jin L; Thompson GB; Lloyd RV
Am J Surg Pathol; 2010 Jan; 34(1):44-52. PubMed ID: 19956062
[TBL] [Abstract] [Full Text] [Related]
13. Mantle cell lymphoma: clinical features, treatment and prognosis of 94 patients.
Oinonen R; Franssila K; Teerenhovi L; Lappalainen K; Elonen E
Eur J Cancer; 1998 Feb; 34(3):329-36. PubMed ID: 9640217
[TBL] [Abstract] [Full Text] [Related]
